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What’s the most practical way to 
rule out adrenal insufficiency?
Evidence-based answer
A morning serum cortisol level >13 mcg/dL 
reliably rules out adrenal insufficiency, 
and the test is easy and safe to perform. 
Because of low specificity, patients 
with a level of ≤13 mcg/dL need 
further evaluation with the cosyntropin 
stimulation test (CsT) (strength of 
recommendation [sOr]: A, meta-analysis 
of diagnostic cohort studies). 
 The 250 mcg CsT requires intravenous 
(IV) or intramuscular (IM) administration of 
cosyntropin and multiple blood draws; a 
normal response reliably rules out primary 
adrenal insufficiency (sOr: B, meta-analysis 
of lower-quality diagnostic cohort studies) 
and moderately decreases the likelihood of 
secondary adrenal insufficiency (sOr: A, 
meta-analysis of diagnostic cohort studies). 
The 1 mcg CsT has better diagnostic 
discrimination, but requires an extra step 
to dilute the cosyntropin (sOr: A, meta-
analysis of diagnostic cohort studies).
z Evidence summary
The morning serum cortisol level is the 
most convenient test for adrenal insuffi-
ciency because it requires a single blood 
draw. The 250 mcg CST involves IV or 
IM administration of cosyntropin and 
several blood draws. The 1 mcg CST, 
introduced to improve detection of par-
tial and secondary adrenal insufficiency, 
requires dilution of the cosyntropin be-
fore administration because the smallest 
available dose is 250 mcg. 
The insulin tolerance test is widely 
considered the gold standard, but re-
quires close observation, is unpleasant 
for the patient, and carries some risk. 
Metyrapone and corticotropin-releasing 
hormone tests are not widely available.1 
Negative CST rules out  
primary insufficiency
Researchers conducting a meta-analysis of 
the CST in diagnosing both primary and 
secondary adrenal insufficiency searched 
MEDLINE for English-language studies 
from 1966 to 2002 and used summary 
receiver-operating characteristic (ROC) 
curves to combine the sensitivities and 
specificities from individual studies.2 Four 
studies of primary adrenal insufficiency 
showed a negative likelihood ratio of 
0.026 for the 250 mcg CST. A negative 
CST would, therefore, significantly de-
crease the post-test probability of primary 
adrenal insufficiency and effectively rule 
out the condition. 
However, primary adrenal insuffi-
ciency was already established in the 4 
studies, and consecutive testing with an 
accepted gold standard was not done. 
Thus, the studies likely overestimate the 
accuracy of the CST test characteristics. 
Using CST results  
for secondary insufficiency 
Twenty studies evaluating the 250 mcg 
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CST for diagnosing secondary adrenal 
insufficiency were of higher quality. They 
included patients with and without dis-
ease and compared the CST with gold-
standard tests, either the insulin tolerance 
test or metyrapone test. The summary 
ROC curve indicated a negative likeli-
hood ratio of 0.45, which would decrease 
only moderately the post-test probability 
of secondary adrenal insufficiency. 
The 1 mcg CST:   
More discriminating than 250 mcg 
Using a ROC curve generated from 22 
studies, the authors found the test char-
acteristics of the 250 mcg CST and the 
1 mcg CST to be similar. Only 7 of these 
studies included paired data for the stan-
dard- and low-dose CST in the same 
patients, however. In the 7 studies with 
paired data, the 1 mcg CST had bet-
ter diagnostic discrimination, based on 
a larger area under the ROC, than the 
250 mcg CST. 
13 mcg/dL is the rule-out threshold 
for morning serum cortisol 
A subsequent meta-analysis, based on 
a PubMed search of English-language 
studies from 1966 to 2006, compared the 
performance of morning serum cortisol, 
the 1 mcg CST, and the 250 mcg CST for 
diagnosing secondary adrenal insufficien-
cy. This analysis used patient-level data 
obtained from the original investigators 
instead of reported study-level results.3 
Data from patients described as normal, 
healthy control subjects were excluded.
Studies included in the meta-analysis 
used an accepted gold-standard test, such 
as the insulin tolerance test or metyra-
pone test. Studies that were performed in 
a critical care setting or used older, less 
reliable cortisol assays were excluded, as 
were studies for which patient-level data 
couldn’t be obtained. Three new studies 
were included, and 12 of the previously 
used studies were excluded.
Instead of using the reported cortisol 
cutoff levels, the authors defined a nega-
tive test as the mean cortisol level (the 
“rule-out threshold”) above which the 
negative likelihood ratio of adrenal in-
sufficiency is <0.15. The rule-out thresh-
olds for morning serum cortisol, 1 mcg 
CST, and 250 mcg CST were 13, 22, and 
30 mcg/dL, respectively. 
An optimal testing strategy  
for secondary insufficiency
The authors proposed an optimal test-
ing strategy for secondary adrenal insuf-
ficiency (assuming a low or moderate 
pretest probability) that starts with a 
morning serum cortisol measurement: 
•  A serum cortisol level >13 mcg/dL 
can effectively rule out adrenal in-
sufficiency.
•  If the morning serum cortisol 
is <13 mcg/dL, a 1 mcg CST 
>22 mcg/dL can rule out adrenal 
insufficiency.
•  Patients would need an insu-
lin tolerance test or metyrapone 
test only if the low-dose CST is 
<22 mcg/dL.
Recommendations
Williams Textbook of Endocrinology 
states that a basal cortisol level higher 
than 14.5 mcg/dL invariably indicates 
an intact hypothalamic-pituitary-adrenal 
axis. However, to confirm the diagnosis 
of adrenal insufficiency, all patients, ex-
cept those with a recent pituitary insult, 
should undergo a CST. An insulin toler-
ance test should be done only if the patient 
has a subnormal response to cosyntropin 
(to rule out a false-positive CST) or has 
had a recent pituitary insult.4 n
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